A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2

Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized human parainfluenza virus type 3 vector to generate constructs expressing the full spike (S) protein of SARS-CoV-2, its S1 subunit, or the re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:npj vaccines Jg. 7; H. 1; S. 47 - 16
Hauptverfasser: Ilinykh, Philipp A., Periasamy, Sivakumar, Huang, Kai, Kuzmina, Natalia A., Ramanathan, Palaniappan, Meyer, Michelle N., Mire, Chad E., Kuzmin, Ivan V., Bharaj, Preeti, Endsley, Jessica R., Chikina, Maria, Sealfon, Stuart C., Widen, Steven G., Endsley, Mark A., Bukreyev, Alexander
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 25.04.2022
Nature Publishing Group
Nature Portfolio
Schlagworte:
631/250/255/2514
631/250/590/1867
631/326/596/4130
692/420/256/2516
Antibodies
Biomedical and Life Sciences
Biomedicine
COVID-19
COVID-19 vaccines
Immune response
Infectious Diseases
Influenza
Medical Microbiology
Protected animals
Proteins
Public Health
Respiratory tract
Rodents
Severe acute respiratory syndrome coronavirus 2
Vaccine
Vaccines
Virology
ISSN:2059-0105, 2059-0105
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized human parainfluenza virus type 3 vector to generate constructs expressing the full spike (S) protein of SARS-CoV-2, its S1 subunit, or the receptor-binding domain, and tested them in hamsters as single-dose intranasal vaccines. The construct bearing full-length S induced high titers of neutralizing antibodies specific to S protein domains critical to the protein functions. Robust memory T cell responses in the lungs were also induced, which represent an additional barrier to infection and should be less sensitive than the antibody responses to mutations present in SARS-CoV-2 variants. Following SARS-CoV-2 challenge, animals were protected from the disease and detectable viral replication. Vaccination prevented induction of gene pathways associated with inflammation. These results indicate advantages of respiratory vaccination against COVID-19 and inform the design of mucosal SARS-CoV-2 vaccines.
AbstractList Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized human parainfluenza virus type 3 vector to generate constructs expressing the full spike (S) protein of SARS-CoV-2, its S1 subunit, or the receptor-binding domain, and tested them in hamsters as single-dose intranasal vaccines. The construct bearing full-length S induced high titers of neutralizing antibodies specific to S protein domains critical to the protein functions. Robust memory T cell responses in the lungs were also induced, which represent an additional barrier to infection and should be less sensitive than the antibody responses to mutations present in SARS-CoV-2 variants. Following SARS-CoV-2 challenge, animals were protected from the disease and detectable viral replication. Vaccination prevented induction of gene pathways associated with inflammation. These results indicate advantages of respiratory vaccination against COVID-19 and inform the design of mucosal SARS-CoV-2 vaccines.
Abstract Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized human parainfluenza virus type 3 vector to generate constructs expressing the full spike (S) protein of SARS-CoV-2, its S1 subunit, or the receptor-binding domain, and tested them in hamsters as single-dose intranasal vaccines. The construct bearing full-length S induced high titers of neutralizing antibodies specific to S protein domains critical to the protein functions. Robust memory T cell responses in the lungs were also induced, which represent an additional barrier to infection and should be less sensitive than the antibody responses to mutations present in SARS-CoV-2 variants. Following SARS-CoV-2 challenge, animals were protected from the disease and detectable viral replication. Vaccination prevented induction of gene pathways associated with inflammation. These results indicate advantages of respiratory vaccination against COVID-19 and inform the design of mucosal SARS-CoV-2 vaccines.
Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized human parainfluenza virus type 3 vector to generate constructs expressing the full spike (S) protein of SARS-CoV-2, its S1 subunit, or the receptor-binding domain, and tested them in hamsters as single-dose intranasal vaccines. The construct bearing full-length S induced high titers of neutralizing antibodies specific to S protein domains critical to the protein functions. Robust memory T cell responses in the lungs were also induced, which represent an additional barrier to infection and should be less sensitive than the antibody responses to mutations present in SARS-CoV-2 variants. Following SARS-CoV-2 challenge, animals were protected from the disease and detectable viral replication. Vaccination prevented induction of gene pathways associated with inflammation. These results indicate advantages of respiratory vaccination against COVID-19 and inform the design of mucosal SARS-CoV-2 vaccines.Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized human parainfluenza virus type 3 vector to generate constructs expressing the full spike (S) protein of SARS-CoV-2, its S1 subunit, or the receptor-binding domain, and tested them in hamsters as single-dose intranasal vaccines. The construct bearing full-length S induced high titers of neutralizing antibodies specific to S protein domains critical to the protein functions. Robust memory T cell responses in the lungs were also induced, which represent an additional barrier to infection and should be less sensitive than the antibody responses to mutations present in SARS-CoV-2 variants. Following SARS-CoV-2 challenge, animals were protected from the disease and detectable viral replication. Vaccination prevented induction of gene pathways associated with inflammation. These results indicate advantages of respiratory vaccination against COVID-19 and inform the design of mucosal SARS-CoV-2 vaccines.
ArticleNumber 47
Author Mire, Chad E.
Ilinykh, Philipp A.
Kuzmin, Ivan V.
Endsley, Mark A.
Bharaj, Preeti
Periasamy, Sivakumar
Chikina, Maria
Ramanathan, Palaniappan
Kuzmina, Natalia A.
Endsley, Jessica R.
Sealfon, Stuart C.
Bukreyev, Alexander
Meyer, Michelle N.
Huang, Kai
Widen, Steven G.
Author_xml – sequence: 1
  givenname: Philipp A.
  surname: Ilinykh
  fullname: Ilinykh, Philipp A.
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 2
  givenname: Sivakumar
  orcidid: 0000-0002-7038-5140
  surname: Periasamy
  fullname: Periasamy, Sivakumar
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 3
  givenname: Kai
  orcidid: 0000-0002-3373-5594
  surname: Huang
  fullname: Huang, Kai
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 4
  givenname: Natalia A.
  orcidid: 0000-0001-6650-9369
  surname: Kuzmina
  fullname: Kuzmina, Natalia A.
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 5
  givenname: Palaniappan
  surname: Ramanathan
  fullname: Ramanathan, Palaniappan
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 6
  givenname: Michelle N.
  surname: Meyer
  fullname: Meyer, Michelle N.
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 7
  givenname: Chad E.
  orcidid: 0000-0001-7596-1808
  surname: Mire
  fullname: Mire, Chad E.
  organization: Department of Microbiology and Immunology, University of Texas Medical Branch
– sequence: 8
  givenname: Ivan V.
  surname: Kuzmin
  fullname: Kuzmin, Ivan V.
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 9
  givenname: Preeti
  surname: Bharaj
  fullname: Bharaj, Preeti
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory
– sequence: 10
  givenname: Jessica R.
  surname: Endsley
  fullname: Endsley, Jessica R.
  organization: Department of Microbiology and Immunology, University of Texas Medical Branch
– sequence: 11
  givenname: Maria
  surname: Chikina
  fullname: Chikina, Maria
  organization: Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh
– sequence: 12
  givenname: Stuart C.
  surname: Sealfon
  fullname: Sealfon, Stuart C.
  organization: Department of Neurology, Icahn School of Medicine at Mount Sinai
– sequence: 13
  givenname: Steven G.
  surname: Widen
  fullname: Widen, Steven G.
  organization: Department of Biochemistry and Molecular Biology, University of Texas Medical Branch
– sequence: 14
  givenname: Mark A.
  surname: Endsley
  fullname: Endsley, Mark A.
  organization: Department of Microbiology and Immunology, University of Texas Medical Branch
– sequence: 15
  givenname: Alexander
  orcidid: 0000-0002-0342-4824
  surname: Bukreyev
  fullname: Bukreyev, Alexander
  email: alexander.bukreyev@utmb.edu
  organization: Department of Pathology, University of Texas Medical Branch, Galveston National Laboratory, Department of Microbiology and Immunology, University of Texas Medical Branch
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35468973$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAUjFARLaV_gAOyxIVLwInjJL4grVZ8VKqERAtX68V53vUqsRfbWWn5Z_w7nN0W2h568pPfzGg8npfZiXUWs-x1Qd8XlLUfQlXwqshpWeaUVk2Rs2fZWUm5yGlB-cm9-TS7CGFDKS2amvGGvshOGa_qVjTsLPuzIMHY1YDE2OjBQoCB9C4gcZqspxEs2YIHY_Uwof0NZGf8FEjcb5GwfIcqOo892YFSxs4i_aQwENQ6rcwOCdhoOtfv09CTEUfn9-SGKBwG4jFsnQ0zi8Q1kmGyq3DAbb2LiR_IGsYQ0afbVfIQIrlefL_Ol-5nXr7KnmsYAl7cnufZj8-fbpZf86tvXy6Xi6tc8YrGvAdV0bZhjS54zbQQTZoF14pVWqQYSlXQWjPRdlpQVMh6Doxr6ERNoeo1O88uj7q9g43cejOC30sHRh4unF9J8NGoAaVudCtqrEBrUXXYQqMKRmvWFxSg7fqk9fGotZ26EXuFc-bDA9GHG2vWcuV2UqQvF5QngXe3At79mjBEOZowhwkW3RRkWXOenlmzNkHfPoJu3ORtimpGVaItBS8T6s19R_-s3DUkAdojQHkXgkctlYkQjZsNmkEWVM59lMc-ytRHeeijnKnlI-qd-pMkdiSFBLYr9P9tP8H6C1TQ9WA
CitedBy_id crossref_primary_10_1038_s41392_023_01408_5
crossref_primary_10_1080_14712598_2022_2156284
crossref_primary_10_3389_fphar_2023_1292479
crossref_primary_10_1016_j_cclet_2025_111213
crossref_primary_10_3390_v14061127
crossref_primary_10_1038_s41392_024_01917_x
crossref_primary_10_3390_vaccines12070783
crossref_primary_10_14814_phy2_70497
Cites_doi 10.1016/j.chom.2020.12.010
10.1016/j.chom.2020.03.023
10.1016/j.coviro.2021.03.009
10.1038/s41467-020-17488-8
10.1016/j.chom.2020.04.004
10.1126/science.abc6284
10.1136/thoraxjnl-2015-207020
10.1038/s41564-021-00932-w
10.1073/pnas.2009799117
10.1016/j.celrep.2021.109400
10.1093/nar/gkn923
10.1038/s41467-020-20247-4
10.1016/j.immuni.2020.04.023
10.1371/journal.ppat.1009383
10.1038/s41586-020-2608-y
10.1016/j.cell.2020.06.035
10.1038/s41586-020-2571-7
10.1038/s41586-020-2456-9
10.1126/science.abb2507
10.1016/j.coviro.2021.07.004
10.1038/s41591-021-01377-8
10.1016/j.celrep.2021.108915
10.1038/s41586-020-2607-z
10.1016/j.xcrm.2021.100230
10.1038/nri2448
10.1016/j.cell.2020.02.058
10.1038/s41594-020-0478-5
10.1126/science.abb9983
10.1128/JVI.72.2.891-899.1998
10.1016/j.coviro.2019.01.003
10.1128/JVI.80.5.2267-2279.2006
10.1056/NEJMoa2035389
10.1126/science.aad5224
10.1128/JVI.00105-07
10.1056/NEJMoa2001017
10.1016/S0140-6736(21)00234-8
10.1038/s41467-021-23942-y
10.1101/gr.234807.118
10.1371/journal.ppat.1007204
10.1056/NEJMoa2034577
10.1038/s41586-020-2355-0
10.1056/NEJMsr2105280
10.1038/s41586-020-2179-y
10.1016/S0140-6736(20)30183-5
10.1128/JVI.00919-06
10.1016/j.immuni.2020.06.001
10.1056/NEJMoa2026920
10.1038/s41591-021-01347-0
10.1128/JVI.06048-11
10.1038/s41592-019-0456-1
10.1126/science.aad6117
10.1006/viro.1997.8697
10.3201/eid2606.200516
10.1038/s41467-020-18077-5
10.1038/nprot.2008.211
10.1186/1471-2105-10-161
10.1038/nri3251
10.1093/bioinformatics/btt656
10.1016/j.celrep.2021.109452
10.1016/j.chom.2021.06.016
10.1038/s41467-020-17972-1
10.1016/j.cell.2020.08.026
10.1126/science.abc1932
10.1016/j.cell.2020.06.008
10.1038/s41467-020-16505-0
10.1128/JVI.02980-14
10.1111/pim.12358
10.1016/S0140-6736(04)15788-7
10.1016/j.cell.2020.09.037
10.1038/s41467-020-16638-2
10.1371/journal.ppat.1009064
10.1371/journal.pone.0035421
10.1038/s41541-021-00352-1
10.1093/bioinformatics/bts635
10.1093/bioinformatics/btt285
10.1128/jcm.29.6.1175-1182.1991
10.1186/s13059-014-0550-8
10.1016/S0140-6736(21)00432-3
10.1038/s41586-020-03041-6
10.1016/j.cell.2020.02.052
10.1016/j.chom.2021.02.019
10.1128/JVI.01845-18
10.1126/sciimmunol.abc8413
10.1016/j.virol.2008.04.029
10.1136/thoraxjnl-2021-217561
10.1016/j.virol.2010.01.015
10.1172/JCI148036
10.1073/pnas.2026153118
10.1126/sciadv.abi5246
10.1007/978-3-662-56004-4
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
88C
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M0T
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1038/s41541-022-00471-3
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & allied health premium.
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database (ProQuest)
ProQuest Health & Medical Collection
Healthcare Administration Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Public Health
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

PubMed
Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 2059-0105
EndPage 16
ExternalDocumentID oai_doaj_org_article_f7f896e4aff94be8a7c13063d10aa8bd
PMC9038905
35468973
10_1038_s41541_022_00471_3
Genre Journal Article
GrantInformation_xml – fundername: University of Texas Medical Branch at Galveston | Institute for Translational Sciences, University of Texas Medical Branch (Institute for Translational Sciences at UTMB)
  grantid: N/A
  funderid: https://doi.org/10.13039/100009259
– fundername: University of Texas Medical Branch at Galveston | Institute for Translational Sciences, University of Texas Medical Branch (Institute for Translational Sciences at UTMB)
  grantid: N/A
– fundername: ;
  grantid: N/A
GroupedDBID 0R~
53G
5VS
7RV
7X7
8C1
8FI
8FJ
AAJSJ
AASML
ABUWG
ACGFS
ADBBV
AEUYN
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BCNDV
BENPR
C6C
CCPQU
EBLON
EBS
ECGQY
FYUFA
GROUPED_DOAJ
HMCUK
HYE
K9-
KQ8
M0R
M0T
M~E
NAO
NAPCQ
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PUEGO
RNT
RPM
SNYQT
UKHRP
AAYXX
AFFHD
CITATION
AJTQC
ALIPV
NPM
3V.
7XB
8FK
COVID
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c540t-dac408737f1563f99773795fc34f95462c106f398bf90ece3d5a35fab960a4df3
IEDL.DBID 7X7
ISICitedReferencesCount 8
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000787300600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2059-0105
IngestDate Tue Oct 14 18:47:20 EDT 2025
Tue Nov 04 02:03:21 EST 2025
Thu Oct 02 07:05:19 EDT 2025
Sat Nov 01 15:01:44 EDT 2025
Thu Apr 03 06:53:03 EDT 2025
Sat Nov 29 06:30:51 EST 2025
Tue Nov 18 22:10:18 EST 2025
Sun Aug 31 08:58:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-dac408737f1563f99773795fc34f95462c106f398bf90ece3d5a35fab960a4df3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-3373-5594
0000-0001-6650-9369
0000-0001-7596-1808
0000-0002-7038-5140
0000-0002-0342-4824
OpenAccessLink https://www.proquest.com/docview/2654982952?pq-origsite=%requestingapplication%
PMID 35468973
PQID 2654982952
PQPubID 4669711
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_f7f896e4aff94be8a7c13063d10aa8bd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9038905
proquest_miscellaneous_2655563638
proquest_journals_2654982952
pubmed_primary_35468973
crossref_citationtrail_10_1038_s41541_022_00471_3
crossref_primary_10_1038_s41541_022_00471_3
springer_journals_10_1038_s41541_022_00471_3
PublicationCentury 2000
PublicationDate 2022-04-25
PublicationDateYYYYMMDD 2022-04-25
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-25
  day: 25
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle npj vaccines
PublicationTitleAbbrev npj Vaccines
PublicationTitleAlternate NPJ Vaccines
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Xie (CR31) 2020; 27
Voysey (CR17) 2021; 397
Shang (CR29) 2020; 581
Feng (CR47) 2020; 11
Wang (CR21) 2020; 182
Kolakofsky (CR82) 1998; 72
Corti (CR62) 2016; 351
Lycke (CR25) 2012; 12
Zhu (CR1) 2020; 382
Harcourt (CR78) 2020; 26
Malherbe (CR42) 2021; 6
Luo, Friedman, Shedden, Hankenson, Woolf (CR39) 2009; 10
CR76
Robbiani (CR9) 2020; 584
CR75
Huang da, Sherman, Lempicki (CR90) 2009; 37
Hennrich (CR44) 2021; 17
CR72
Piccoli (CR11) 2020; 183
Bukreyev (CR77) 2007; 81
Mercado (CR18) 2020; 586
Imai (CR30) 2020; 117
Huang (CR37) 2020; 395
Love, Huber, Anders (CR88) 2014; 15
Baden (CR15) 2021; 384
King, Milligan, West, Schendel, Ollmann Saphire (CR66) 2019; 34
Hassan (CR53) 2020; 183
Kaewraemruaen, Sermswan, Wongratanacheewin (CR84) 2016; 38
Khoury (CR7) 2021; 27
CR5
Krause (CR4) 2021; 385
Wu (CR55) 2020; 11
Kim (CR57) 2020; 27
Bolles (CR69) 2011; 85
Hassan (CR50) 2021; 2
Huang da, Sherman, Lempicki (CR89) 2009; 4
Luo, Brouwer (CR91) 2013; 29
Zhou (CR54) 2021; 29
Ni (CR12) 2020; 52
CR41
Zhang (CR36) 2020; 583
Clements (CR27) 1991; 29
CR83
CR80
Li (CR60) 2021; 34
Wrapp (CR28) 2020; 367
Mosser, Edwards (CR73) 2008; 8
Smith (CR23) 2020; 11
Mao, Zaslavsky, Hartmann, Sealfon, Chikina (CR38) 2019; 16
Liu (CR10) 2020; 584
Andreano, Rappuoli (CR3) 2021; 27
Ilinykh (CR67) 2018; 14
Seydoux (CR59) 2020; 53
Stevens, Oguntuyo, Lee (CR33) 2021; 50
Keech (CR22) 2020; 383
CR13
Poh (CR63) 2020; 11
Dobin (CR86) 2013; 29
CR56
Kurup (CR43) 2021; 17
Routhu (CR46) 2021; 12
Byrne, Mathie, Gregory, Lloyd (CR74) 2015; 70
Hassan (CR52) 2021; 36
Hoffmann (CR64) 2020; 181
Bukreyev (CR79) 2006; 80
CR51
Honda-Okubo (CR71) 2015; 89
Watanabe, Allen, Wrapp, McLellan, Crispin (CR35) 2020; 369
Walls (CR8) 2020; 181
Lee, Lowen (CR58) 2021; 48
Foley (CR85) 2019; 29
Gao (CR20) 2020; 369
Bukreyev, Skiadopoulos, Murphy, Collins (CR26) 2006; 80
Tseng (CR70) 2012; 7
Liao, Smyth, Shi (CR87) 2014; 30
Subbarao (CR2) 2021; 29
Misasi (CR61) 2016; 351
Lau (CR6) 2021; 12
Xiong (CR34) 2020; 27
Polack (CR14) 2020; 383
Yu (CR24) 2020; 369
Jiang (CR40) 2020; 11
Durbin (CR81) 1997; 235
Logunov (CR16) 2021; 397
van Doremalen (CR19) 2020; 586
Bricker (CR49) 2021; 36
Konings (CR32) 2021; 6
Dai (CR45) 2020; 182
McMahan (CR68) 2021; 590
Liu (CR65) 2004; 363
Ku (CR48) 2021; 29
CS Stevens (471_CR33) 2021; 50
S Wu (471_CR55) 2020; 11
AJ Byrne (471_CR74) 2015; 70
L Liu (471_CR10) 2020; 584
471_CR5
S Liu (471_CR65) 2004; 363
ML Clements (471_CR27) 1991; 29
MW Ku (471_CR48) 2021; 29
JW Foley (471_CR85) 2019; 29
N van Doremalen (471_CR19) 2020; 586
471_CR83
471_CR80
D Zhou (471_CR54) 2021; 29
M Hoffmann (471_CR64) 2020; 181
A Bukreyev (471_CR77) 2007; 81
471_CR41
Y Liao (471_CR87) 2014; 30
K Subbarao (471_CR2) 2021; 29
NB Mercado (471_CR18) 2020; 586
DM Mosser (471_CR73) 2008; 8
D Kolakofsky (471_CR82) 1998; 72
X Zhang (471_CR36) 2020; 583
W Mao (471_CR38) 2019; 16
W Huang da (471_CR89) 2009; 4
AO Hassan (471_CR53) 2020; 183
A Durbin (471_CR81) 1997; 235
J Harcourt (471_CR78) 2020; 26
M Imai (471_CR30) 2020; 117
W Luo (471_CR91) 2013; 29
471_CR72
AA Hennrich (471_CR44) 2021; 17
LR Baden (471_CR15) 2021; 384
471_CR76
X Xiong (471_CR34) 2020; 27
Y Li (471_CR60) 2021; 34
M Bolles (471_CR69) 2011; 85
471_CR75
Y Watanabe (471_CR35) 2020; 369
YI Kim (471_CR57) 2020; 27
C Kaewraemruaen (471_CR84) 2016; 38
AO Hassan (471_CR50) 2021; 2
DF Robbiani (471_CR9) 2020; 584
EHY Lau (471_CR6) 2021; 12
X Xie (471_CR31) 2020; 27
M Voysey (471_CR17) 2021; 397
L Ni (471_CR12) 2020; 52
LB King (471_CR66) 2019; 34
TRF Smith (471_CR23) 2020; 11
Q Gao (471_CR20) 2020; 369
W Luo (471_CR39) 2009; 10
471_CR13
L Feng (471_CR47) 2020; 11
471_CR56
A Bukreyev (471_CR26) 2006; 80
TL Bricker (471_CR49) 2021; 36
DC Malherbe (471_CR42) 2021; 6
A Bukreyev (471_CR79) 2006; 80
E Andreano (471_CR3) 2021; 27
J Shang (471_CR29) 2020; 581
CM Poh (471_CR63) 2020; 11
L Piccoli (471_CR11) 2020; 183
Y Honda-Okubo (471_CR71) 2015; 89
C Huang (471_CR37) 2020; 395
A Dobin (471_CR86) 2013; 29
L Dai (471_CR45) 2020; 182
MI Love (471_CR88) 2014; 15
N Zhu (471_CR1) 2020; 382
NK Routhu (471_CR46) 2021; 12
AO Hassan (471_CR52) 2021; 36
CY Lee (471_CR58) 2021; 48
CT Tseng (471_CR70) 2012; 7
FP Polack (471_CR14) 2020; 383
AC Walls (471_CR8) 2020; 181
PR Krause (471_CR4) 2021; 385
H Wang (471_CR21) 2020; 182
K McMahan (471_CR68) 2021; 590
N Lycke (471_CR25) 2012; 12
D Kurup (471_CR43) 2021; 17
F Konings (471_CR32) 2021; 6
D Wrapp (471_CR28) 2020; 367
PA Ilinykh (471_CR67) 2018; 14
DS Khoury (471_CR7) 2021; 27
471_CR51
J Misasi (471_CR61) 2016; 351
E Seydoux (471_CR59) 2020; 53
HW Jiang (471_CR40) 2020; 11
D Corti (471_CR62) 2016; 351
W Huang da (471_CR90) 2009; 37
DY Logunov (471_CR16) 2021; 397
C Keech (471_CR22) 2020; 383
J Yu (471_CR24) 2020; 369
References_xml – volume: 29
  start-page: 236
  year: 2021
  end-page: 249.e236
  ident: CR48
  article-title: Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.12.010
– volume: 27
  start-page: 704
  year: 2020
  end-page: 709.e702
  ident: CR57
  article-title: Infection and rapid transmission of SARS-CoV-2 in ferrets
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.03.023
– volume: 48
  start-page: 73
  year: 2021
  end-page: 81
  ident: CR58
  article-title: Animal models for SARS-CoV-2
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2021.03.009
– volume: 11
  year: 2020
  ident: CR40
  article-title: SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-17488-8
– volume: 27
  start-page: 841
  year: 2020
  end-page: 848.e843
  ident: CR31
  article-title: An infectious cDNA clone of SARS-CoV-2
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.04.004
– volume: 369
  start-page: 806
  year: 2020
  end-page: 811
  ident: CR24
  article-title: DNA vaccine protection against SARS-CoV-2 in rhesus macaques
  publication-title: Science
  doi: 10.1126/science.abc6284
– ident: CR51
– volume: 70
  start-page: 1189
  year: 2015
  end-page: 1196
  ident: CR74
  article-title: Pulmonary macrophages: key players in the innate defence of the airways
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2015-207020
– volume: 6
  start-page: 821
  year: 2021
  end-page: 823
  ident: CR32
  article-title: SARS-CoV-2 variants of interest and concern naming scheme conducive for global discourse
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-021-00932-w
– volume: 117
  start-page: 16587
  year: 2020
  end-page: 16595
  ident: CR30
  article-title: Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.2009799117
– volume: 36
  start-page: 109400
  year: 2021
  ident: CR49
  article-title: A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109400
– volume: 37
  start-page: 1
  year: 2009
  end-page: 13
  ident: CR90
  article-title: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkn923
– volume: 12
  year: 2021
  ident: CR6
  article-title: Neutralizing antibody titres in SARS-CoV-2 infections
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-20247-4
– volume: 52
  start-page: 971
  year: 2020
  end-page: 977.e973
  ident: CR12
  article-title: Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.023
– volume: 17
  start-page: e1009383
  year: 2021
  ident: CR43
  article-title: Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1009383
– ident: CR80
– volume: 586
  start-page: 578
  year: 2020
  end-page: 582
  ident: CR19
  article-title: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
  publication-title: Nature
  doi: 10.1038/s41586-020-2608-y
– volume: 182
  start-page: 722
  year: 2020
  end-page: 733.e711
  ident: CR45
  article-title: A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.035
– volume: 584
  start-page: 450
  year: 2020
  end-page: 456
  ident: CR10
  article-title: Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
  publication-title: Nature
  doi: 10.1038/s41586-020-2571-7
– volume: 584
  start-page: 437
  year: 2020
  end-page: 442
  ident: CR9
  article-title: Convergent antibody responses to SARS-CoV-2 in convalescent individuals
  publication-title: Nature
  doi: 10.1038/s41586-020-2456-9
– volume: 367
  start-page: 1260
  year: 2020
  end-page: 1263
  ident: CR28
  article-title: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
  publication-title: Science
  doi: 10.1126/science.abb2507
– volume: 50
  start-page: 49
  year: 2021
  end-page: 58
  ident: CR33
  article-title: Proteases and variants: context matters for SARS-CoV-2 entry assays
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2021.07.004
– volume: 27
  start-page: 1205
  year: 2021
  end-page: 1211
  ident: CR7
  article-title: Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01377-8
– volume: 34
  start-page: 108915
  year: 2021
  ident: CR60
  article-title: Linear epitope landscape of the SARS-CoV-2 spike protein constructed from 1,051 COVID-19 patients
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.108915
– volume: 586
  start-page: 583
  year: 2020
  end-page: 588
  ident: CR18
  article-title: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
  publication-title: Nature
  doi: 10.1038/s41586-020-2607-z
– volume: 2
  start-page: 100230
  year: 2021
  ident: CR50
  article-title: A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
  publication-title: Cell Rep. Med.
  doi: 10.1016/j.xcrm.2021.100230
– volume: 8
  start-page: 958
  year: 2008
  end-page: 969
  ident: CR73
  article-title: Exploring the full spectrum of macrophage activation
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2448
– volume: 181
  start-page: 281
  year: 2020
  end-page: 292e286
  ident: CR8
  article-title: Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.058
– ident: CR75
– volume: 27
  start-page: 934
  year: 2020
  end-page: 941
  ident: CR34
  article-title: A thermostable, closed SARS-CoV-2 spike protein trimer
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/s41594-020-0478-5
– volume: 369
  start-page: 330
  year: 2020
  end-page: 333
  ident: CR35
  article-title: Site-specific glycan analysis of the SARS-CoV-2 spike
  publication-title: Science (New York, N. Y.)
  doi: 10.1126/science.abb9983
– volume: 72
  start-page: 891
  year: 1998
  end-page: 899
  ident: CR82
  article-title: Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.2.891-899.1998
– volume: 34
  start-page: 140
  year: 2019
  end-page: 148
  ident: CR66
  article-title: Achieving cross-reactivity with pan-ebolavirus antibodies
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2019.01.003
– volume: 80
  start-page: 2267
  year: 2006
  end-page: 2279
  ident: CR79
  article-title: A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge
  publication-title: J. Virol.
  doi: 10.1128/JVI.80.5.2267-2279.2006
– volume: 384
  start-page: 403
  year: 2021
  end-page: 416
  ident: CR15
  article-title: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2035389
– volume: 351
  start-page: 1339
  year: 2016
  end-page: 1342
  ident: CR62
  article-title: Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
  publication-title: Science (New York, N. Y.)
  doi: 10.1126/science.aad5224
– volume: 81
  start-page: 6379
  year: 2007
  end-page: 6388
  ident: CR77
  article-title: Successful topical respiratory tract immunization of primates against Ebola virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.00105-07
– volume: 382
  start-page: 727
  year: 2020
  end-page: 733
  ident: CR1
  article-title: A novel coronavirus from patients with pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 397
  start-page: 671
  year: 2021
  end-page: 681
  ident: CR16
  article-title: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(21)00234-8
– volume: 12
  year: 2021
  ident: CR46
  article-title: SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-23942-y
– volume: 29
  start-page: 1816
  year: 2019
  end-page: 1825
  ident: CR85
  article-title: Gene expression profiling of single cells from archival tissue with laser-capture microdissection and Smart-3SEQ
  publication-title: Genome Res.
  doi: 10.1101/gr.234807.118
– volume: 14
  start-page: e1007204
  year: 2018
  ident: CR67
  article-title: Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1007204
– volume: 383
  start-page: 2603
  year: 2020
  end-page: 2615
  ident: CR14
  article-title: Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2034577
– volume: 583
  start-page: 437
  year: 2020
  end-page: 440
  ident: CR36
  article-title: Viral and host factors related to the clinical outcome of COVID-19
  publication-title: Nature
  doi: 10.1038/s41586-020-2355-0
– volume: 385
  start-page: 179
  year: 2021
  end-page: 186
  ident: CR4
  article-title: SARS-CoV-2 variants and vaccines
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMsr2105280
– ident: CR5
– volume: 581
  start-page: 221
  year: 2020
  end-page: 224
  ident: CR29
  article-title: Structural basis of receptor recognition by SARS-CoV-2
  publication-title: Nature
  doi: 10.1038/s41586-020-2179-y
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: CR37
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 80
  start-page: 10293
  year: 2006
  end-page: 10306
  ident: CR26
  article-title: Nonsegmented negative-strand viruses as vaccine vectors
  publication-title: J. Virol.
  doi: 10.1128/JVI.00919-06
– volume: 53
  start-page: 98
  year: 2020
  end-page: 105.e105
  ident: CR59
  article-title: Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.06.001
– volume: 383
  start-page: 2320
  year: 2020
  end-page: 2332
  ident: CR22
  article-title: Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2026920
– volume: 27
  start-page: 759
  year: 2021
  end-page: 761
  ident: CR3
  article-title: SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01347-0
– volume: 85
  start-page: 12201
  year: 2011
  end-page: 12215
  ident: CR69
  article-title: A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge
  publication-title: J. Virol.
  doi: 10.1128/JVI.06048-11
– volume: 16
  start-page: 607
  year: 2019
  end-page: 610
  ident: CR38
  article-title: Pathway-level information extractor (PLIER) for gene expression data
  publication-title: Nat. Methods
  doi: 10.1038/s41592-019-0456-1
– volume: 351
  start-page: 1343
  year: 2016
  end-page: 1346
  ident: CR61
  article-title: Structural and molecular basis for Ebola virus neutralization by protective human antibodies
  publication-title: Science
  doi: 10.1126/science.aad6117
– volume: 235
  start-page: 232
  year: 1997
  end-page: 232
  ident: CR81
  article-title: Recovery of infectious human parainfluenza virus type 3 from cDNA
  publication-title: Virology
  doi: 10.1006/viro.1997.8697
– volume: 26
  start-page: 1266
  year: 2020
  end-page: 1273
  ident: CR78
  article-title: Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2606.200516
– ident: CR72
– volume: 11
  year: 2020
  ident: CR47
  article-title: An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-18077-5
– volume: 4
  start-page: 44
  year: 2009
  end-page: 57
  ident: CR89
  article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.211
– volume: 10
  year: 2009
  ident: CR39
  article-title: GAGE: generally applicable gene set enrichment for pathway analysis
  publication-title: BMC Bioinforma.
  doi: 10.1186/1471-2105-10-161
– volume: 12
  start-page: 592
  year: 2012
  end-page: 605
  ident: CR25
  article-title: Recent progress in mucosal vaccine development: potential and limitations
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3251
– volume: 30
  start-page: 923
  year: 2014
  end-page: 930
  ident: CR87
  article-title: featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
  publication-title: Bioinformatics (Oxf., Engl.)
  doi: 10.1093/bioinformatics/btt656
– volume: 36
  start-page: 109452
  year: 2021
  ident: CR52
  article-title: An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109452
– volume: 29
  start-page: 1111
  year: 2021
  end-page: 1123
  ident: CR2
  article-title: The success of SARS-CoV-2 vaccines and challenges ahead
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2021.06.016
– ident: CR56
– volume: 11
  year: 2020
  ident: CR55
  article-title: A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-17972-1
– volume: 183
  start-page: 169
  year: 2020
  end-page: 184.e113
  ident: CR53
  article-title: A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.026
– volume: 369
  start-page: 77
  year: 2020
  end-page: 81
  ident: CR20
  article-title: Development of an inactivated vaccine candidate for SARS-CoV-2
  publication-title: Science (New York, N. Y.)
  doi: 10.1126/science.abc1932
– volume: 182
  start-page: 713
  year: 2020
  end-page: 721.e719
  ident: CR21
  article-title: Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.008
– volume: 11
  year: 2020
  ident: CR23
  article-title: Immunogenicity of a DNA vaccine candidate for COVID-19
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-16505-0
– volume: 89
  start-page: 2995
  year: 2015
  end-page: 3007
  ident: CR71
  article-title: Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology
  publication-title: J. Virol.
  doi: 10.1128/JVI.02980-14
– volume: 38
  start-page: 688
  year: 2016
  end-page: 697
  ident: CR84
  article-title: Induction of regulatory T cells by Opisthorchis viverrini
  publication-title: Parasite Immunol.
  doi: 10.1111/pim.12358
– volume: 363
  start-page: 938
  year: 2004
  end-page: 947
  ident: CR65
  article-title: Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(04)15788-7
– volume: 183
  start-page: 1024
  year: 2020
  end-page: 1042.e1021
  ident: CR11
  article-title: Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
  publication-title: Cell
  doi: 10.1016/j.cell.2020.09.037
– volume: 11
  year: 2020
  ident: CR63
  article-title: Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-16638-2
– volume: 17
  start-page: e1009064
  year: 2021
  ident: CR44
  article-title: Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: protection of mice after a single immunization
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1009064
– volume: 7
  start-page: e35421
  year: 2012
  ident: CR70
  article-title: Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0035421
– volume: 6
  year: 2021
  ident: CR42
  article-title: A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00352-1
– volume: 29
  start-page: 15
  year: 2013
  end-page: 21
  ident: CR86
  article-title: STAR: ultrafast universal RNA-seq aligner
  publication-title: Bioinformatics (Oxf., Engl.)
  doi: 10.1093/bioinformatics/bts635
– ident: CR13
– volume: 29
  start-page: 1830
  year: 2013
  end-page: 1831
  ident: CR91
  article-title: Pathview: an R/Bioconductor package for pathway-based data integration and visualization
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btt285
– volume: 29
  start-page: 1175
  year: 1991
  end-page: 1182
  ident: CR27
  article-title: Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/jcm.29.6.1175-1182.1991
– volume: 15
  year: 2014
  ident: CR88
  article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
  publication-title: Genome Biol.
  doi: 10.1186/s13059-014-0550-8
– volume: 397
  start-page: 881
  year: 2021
  end-page: 891
  ident: CR17
  article-title: Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(21)00432-3
– volume: 590
  start-page: 630
  year: 2021
  end-page: 634
  ident: CR68
  article-title: Correlates of protection against SARS-CoV-2 in rhesus macaques
  publication-title: Nature
  doi: 10.1038/s41586-020-03041-6
– volume: 181
  start-page: 271
  year: 2020
  end-page: 280.e278
  ident: CR64
  article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.052
– ident: CR76
– ident: CR83
– ident: CR41
– volume: 29
  start-page: 551
  year: 2021
  end-page: 563.e555
  ident: CR54
  article-title: Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2021.02.019
– volume: 70
  start-page: 1189
  year: 2015
  ident: 471_CR74
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2015-207020
– volume: 384
  start-page: 403
  year: 2021
  ident: 471_CR15
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2035389
– volume: 383
  start-page: 2320
  year: 2020
  ident: 471_CR22
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2026920
– volume: 27
  start-page: 841
  year: 2020
  ident: 471_CR31
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.04.004
– volume: 17
  start-page: e1009064
  year: 2021
  ident: 471_CR44
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1009064
– volume: 29
  start-page: 236
  year: 2021
  ident: 471_CR48
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.12.010
– ident: 471_CR80
  doi: 10.1128/JVI.01845-18
– volume: 29
  start-page: 1816
  year: 2019
  ident: 471_CR85
  publication-title: Genome Res.
  doi: 10.1101/gr.234807.118
– volume: 586
  start-page: 578
  year: 2020
  ident: 471_CR19
  publication-title: Nature
  doi: 10.1038/s41586-020-2608-y
– volume: 12
  year: 2021
  ident: 471_CR46
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-23942-y
– volume: 367
  start-page: 1260
  year: 2020
  ident: 471_CR28
  publication-title: Science
  doi: 10.1126/science.abb2507
– volume: 29
  start-page: 15
  year: 2013
  ident: 471_CR86
  publication-title: Bioinformatics (Oxf., Engl.)
  doi: 10.1093/bioinformatics/bts635
– ident: 471_CR41
  doi: 10.1126/sciimmunol.abc8413
– volume: 382
  start-page: 727
  year: 2020
  ident: 471_CR1
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 52
  start-page: 971
  year: 2020
  ident: 471_CR12
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.023
– volume: 11
  year: 2020
  ident: 471_CR63
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-16638-2
– volume: 48
  start-page: 73
  year: 2021
  ident: 471_CR58
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2021.03.009
– volume: 17
  start-page: e1009383
  year: 2021
  ident: 471_CR43
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1009383
– volume: 37
  start-page: 1
  year: 2009
  ident: 471_CR90
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkn923
– ident: 471_CR5
– volume: 351
  start-page: 1343
  year: 2016
  ident: 471_CR61
  publication-title: Science
  doi: 10.1126/science.aad6117
– volume: 38
  start-page: 688
  year: 2016
  ident: 471_CR84
  publication-title: Parasite Immunol.
  doi: 10.1111/pim.12358
– volume: 15
  year: 2014
  ident: 471_CR88
  publication-title: Genome Biol.
  doi: 10.1186/s13059-014-0550-8
– volume: 383
  start-page: 2603
  year: 2020
  ident: 471_CR14
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2034577
– volume: 36
  start-page: 109400
  year: 2021
  ident: 471_CR49
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109400
– ident: 471_CR75
  doi: 10.1016/j.virol.2008.04.029
– volume: 81
  start-page: 6379
  year: 2007
  ident: 471_CR77
  publication-title: J. Virol.
  doi: 10.1128/JVI.00105-07
– volume: 72
  start-page: 891
  year: 1998
  ident: 471_CR82
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.2.891-899.1998
– ident: 471_CR13
  doi: 10.1136/thoraxjnl-2021-217561
– volume: 584
  start-page: 450
  year: 2020
  ident: 471_CR10
  publication-title: Nature
  doi: 10.1038/s41586-020-2571-7
– volume: 16
  start-page: 607
  year: 2019
  ident: 471_CR38
  publication-title: Nat. Methods
  doi: 10.1038/s41592-019-0456-1
– volume: 182
  start-page: 722
  year: 2020
  ident: 471_CR45
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.035
– volume: 385
  start-page: 179
  year: 2021
  ident: 471_CR4
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMsr2105280
– volume: 89
  start-page: 2995
  year: 2015
  ident: 471_CR71
  publication-title: J. Virol.
  doi: 10.1128/JVI.02980-14
– volume: 363
  start-page: 938
  year: 2004
  ident: 471_CR65
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(04)15788-7
– volume: 50
  start-page: 49
  year: 2021
  ident: 471_CR33
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2021.07.004
– volume: 11
  year: 2020
  ident: 471_CR47
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-18077-5
– volume: 183
  start-page: 169
  year: 2020
  ident: 471_CR53
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.026
– volume: 117
  start-page: 16587
  year: 2020
  ident: 471_CR30
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.2009799117
– ident: 471_CR76
  doi: 10.1016/j.virol.2010.01.015
– volume: 27
  start-page: 759
  year: 2021
  ident: 471_CR3
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01347-0
– volume: 6
  start-page: 821
  year: 2021
  ident: 471_CR32
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-021-00932-w
– volume: 182
  start-page: 713
  year: 2020
  ident: 471_CR21
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.008
– volume: 183
  start-page: 1024
  year: 2020
  ident: 471_CR11
  publication-title: Cell
  doi: 10.1016/j.cell.2020.09.037
– volume: 369
  start-page: 806
  year: 2020
  ident: 471_CR24
  publication-title: Science
  doi: 10.1126/science.abc6284
– volume: 586
  start-page: 583
  year: 2020
  ident: 471_CR18
  publication-title: Nature
  doi: 10.1038/s41586-020-2607-z
– volume: 369
  start-page: 77
  year: 2020
  ident: 471_CR20
  publication-title: Science (New York, N. Y.)
  doi: 10.1126/science.abc1932
– volume: 29
  start-page: 1175
  year: 1991
  ident: 471_CR27
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/jcm.29.6.1175-1182.1991
– volume: 29
  start-page: 551
  year: 2021
  ident: 471_CR54
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2021.02.019
– volume: 11
  year: 2020
  ident: 471_CR55
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-17972-1
– ident: 471_CR83
  doi: 10.1172/JCI148036
– ident: 471_CR51
  doi: 10.1073/pnas.2026153118
– volume: 27
  start-page: 1205
  year: 2021
  ident: 471_CR7
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01377-8
– volume: 14
  start-page: e1007204
  year: 2018
  ident: 471_CR67
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1007204
– volume: 34
  start-page: 140
  year: 2019
  ident: 471_CR66
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2019.01.003
– volume: 590
  start-page: 630
  year: 2021
  ident: 471_CR68
  publication-title: Nature
  doi: 10.1038/s41586-020-03041-6
– volume: 10
  year: 2009
  ident: 471_CR39
  publication-title: BMC Bioinforma.
  doi: 10.1186/1471-2105-10-161
– volume: 80
  start-page: 10293
  year: 2006
  ident: 471_CR26
  publication-title: J. Virol.
  doi: 10.1128/JVI.00919-06
– volume: 85
  start-page: 12201
  year: 2011
  ident: 471_CR69
  publication-title: J. Virol.
  doi: 10.1128/JVI.06048-11
– volume: 30
  start-page: 923
  year: 2014
  ident: 471_CR87
  publication-title: Bioinformatics (Oxf., Engl.)
  doi: 10.1093/bioinformatics/btt656
– volume: 34
  start-page: 108915
  year: 2021
  ident: 471_CR60
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.108915
– volume: 27
  start-page: 704
  year: 2020
  ident: 471_CR57
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.03.023
– volume: 26
  start-page: 1266
  year: 2020
  ident: 471_CR78
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2606.200516
– volume: 29
  start-page: 1830
  year: 2013
  ident: 471_CR91
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btt285
– volume: 395
  start-page: 497
  year: 2020
  ident: 471_CR37
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 581
  start-page: 221
  year: 2020
  ident: 471_CR29
  publication-title: Nature
  doi: 10.1038/s41586-020-2179-y
– volume: 80
  start-page: 2267
  year: 2006
  ident: 471_CR79
  publication-title: J. Virol.
  doi: 10.1128/JVI.80.5.2267-2279.2006
– volume: 12
  start-page: 592
  year: 2012
  ident: 471_CR25
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3251
– volume: 4
  start-page: 44
  year: 2009
  ident: 471_CR89
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.211
– volume: 181
  start-page: 281
  year: 2020
  ident: 471_CR8
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.058
– ident: 471_CR56
  doi: 10.1126/sciadv.abi5246
– volume: 27
  start-page: 934
  year: 2020
  ident: 471_CR34
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/s41594-020-0478-5
– volume: 369
  start-page: 330
  year: 2020
  ident: 471_CR35
  publication-title: Science (New York, N. Y.)
  doi: 10.1126/science.abb9983
– volume: 8
  start-page: 958
  year: 2008
  ident: 471_CR73
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2448
– volume: 12
  year: 2021
  ident: 471_CR6
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-20247-4
– volume: 6
  year: 2021
  ident: 471_CR42
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00352-1
– volume: 2
  start-page: 100230
  year: 2021
  ident: 471_CR50
  publication-title: Cell Rep. Med.
  doi: 10.1016/j.xcrm.2021.100230
– volume: 7
  start-page: e35421
  year: 2012
  ident: 471_CR70
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0035421
– volume: 584
  start-page: 437
  year: 2020
  ident: 471_CR9
  publication-title: Nature
  doi: 10.1038/s41586-020-2456-9
– volume: 11
  year: 2020
  ident: 471_CR23
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-16505-0
– volume: 397
  start-page: 881
  year: 2021
  ident: 471_CR17
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(21)00432-3
– volume: 36
  start-page: 109452
  year: 2021
  ident: 471_CR52
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109452
– volume: 351
  start-page: 1339
  year: 2016
  ident: 471_CR62
  publication-title: Science (New York, N. Y.)
  doi: 10.1126/science.aad5224
– ident: 471_CR72
  doi: 10.1007/978-3-662-56004-4
– volume: 235
  start-page: 232
  year: 1997
  ident: 471_CR81
  publication-title: Virology
  doi: 10.1006/viro.1997.8697
– volume: 29
  start-page: 1111
  year: 2021
  ident: 471_CR2
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2021.06.016
– volume: 181
  start-page: 271
  year: 2020
  ident: 471_CR64
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.052
– volume: 397
  start-page: 671
  year: 2021
  ident: 471_CR16
  publication-title: Lancet (Lond., Engl.)
  doi: 10.1016/S0140-6736(21)00234-8
– volume: 583
  start-page: 437
  year: 2020
  ident: 471_CR36
  publication-title: Nature
  doi: 10.1038/s41586-020-2355-0
– volume: 11
  year: 2020
  ident: 471_CR40
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-17488-8
– volume: 53
  start-page: 98
  year: 2020
  ident: 471_CR59
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.06.001
SSID ssj0001763570
Score 2.235073
Snippet Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We utilized...
Abstract Respiratory tract vaccination has an advantage of needle-free delivery and induction of mucosal immune response in the portal of SARS-CoV-2 entry. We...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 47
SubjectTerms 631/250/255/2514
631/250/590/1867
631/326/596/4130
692/420/256/2516
Antibodies
Biomedical and Life Sciences
Biomedicine
COVID-19
COVID-19 vaccines
Immune response
Infectious Diseases
Influenza
Medical Microbiology
Protected animals
Proteins
Public Health
Respiratory tract
Rodents
Severe acute respiratory syndrome coronavirus 2
Vaccine
Vaccines
Virology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQigMXxJvAggYJ7YVGm8ZObB_LihWnVcUWtLfI8YONtJus6rZS-Wf8O8ZO2m55XrhFiZOMPJ_HM_b4G0LeGqY4r8PxM-10ygpXpEJakxYqV0IZxbTOYrEJfnYmLi7k9Fapr5AT1tMD9x137LgTsrRMOSdZbYXiGs1uSc04U0rUJljfjMtbwVRcXYk8a9lwSiaj4tjjTMUwcsbYKzAkjlO6NxNFwv7feZm_Jkv-tGMaJ6LTB-T-4EHCpJf8Iblj20fkaNpTUK9HMNudqPIjOILpjpx6_Zh8n0BYHbiy0IQftcrjt0znLXQOYsE-CGzgTV-75JuCVTNfeggrtUDTVVzjtwZWSocdefyIQWx46NNC0HICaqqpO7PGCwPXIY93DTMI-wMw7_Nxw1uAfidcoaHxsd3AFuHhUl0H5ga8-xVl8As4n3w6T0-6L2n-hHw-_TA7-ZgO5RtSjW7gIjVKs0xwyh3GiNRJ9DQpl4XTlDlZsDLXGI46KkXtZGa1paZQtHCqxqBKMePoU3LQdq19TmBcFko5Zmgd3JGylOh2WsczV1tuc-YSMt6ostIDt3kosXFVxT12Kqpe_RWqv4rqr2hC3m3fuemZPf7a-n1AyLZlYOWONxCr1YDV6l9YTcjhBl_VYCp8lZcYootcFnlC3mwf4yAPmlGt7ZaxTSByQ1uZkGc9HLeSUOxKITlKyPeAuifq_pO2uYxE4jKwK2ZFQkYbSO_E-nNXvPgfXfGS3MvjWGRpXhySg8V8aV-Ru3q1aPz8dRzMPwByH1HW
  priority: 102
  providerName: Directory of Open Access Journals
Title A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2
URI https://link.springer.com/article/10.1038/s41541-022-00471-3
https://www.ncbi.nlm.nih.gov/pubmed/35468973
https://www.proquest.com/docview/2654982952
https://www.proquest.com/docview/2655563638
https://pubmed.ncbi.nlm.nih.gov/PMC9038905
https://doaj.org/article/f7f896e4aff94be8a7c13063d10aa8bd
Volume 7
WOSCitedRecordID wos000787300600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M~E
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Consumer Health Database (subscription)
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M0R
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 7X7
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Healthcare Administration Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: M0T
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthmanagement
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 7RV
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: BENPR
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: 8C1
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2059-0105
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001763570
  issn: 2059-0105
  databaseCode: PIMPY
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JbtswECXapIdeui9qU4MFilwaIbJIieSpcIwE7SGG4biBexIoLokAR0ot24D7Z_27DinZhrvk0gshiJQwEh-HMxzyDUIfNJWM5e74mbIqpIlNQi6MDhMZSy61pEpFPtkEGwz4ZCKG7YJb3W6rXOtEr6h1pdwa-XGcgifDY5HEn26_hy5rlIuutik07qN9lzbb4ZxN2HaNxbOtRe1ZmYjw4xrmKwr-M3hgjiexG5Kd-cjT9v_N1vxzy-RvcVM_HZ09_t8PeYIetYYo7jXIeYrumfIZOhw2TNarIzzeHsyqj_AhHm45rlfP0c8edosMU4MLJ2kpa3iXrmqDK4t93j_sSMWLJgXKD4mXxWxRY7fgi0m49KECo_FSKhfYh5dogFiNm90loIAxdHiRV3oFFxrfuO3AKzzGLsyAZ822XvcUBvMVT0Ff1b5dSzpR42t54wgg4O4VyFDP8UVvdBH2q8swfoG-np2O-5_DNgtEqMCanIdaKhpB3zILriaxAgxWwkRiFaFWJDSNFXi1lgieWxEZZYhOJEmszME3k1Rb8hLtlVVpXiPcTRMpLdUkd1ZNmgqwXo1lkc0NMzG1AequsZCpliLdZeqYZj5UT3jW4CcD_GQePxkJ0MfNM7cNQcidrU8cxDYtHbm3v1HNrrJWV2SWWS5SQ6W1guaGS6bA0kiJ7kZS8lwH6GCNrKzVOHW2hVWA3m-qQVe4npGlqRa-jeODA5UboFcNnjeSEPiVXDCQkO0gfUfU3ZqyuPZ85MKRNEZJgI7WY2Ir1r9_xZu7v-Itehj7YUrDODlAe_PZwrxDD9RyXtSzDozz0WXHj3Zfcih5v9tB-yeng-Go45dWoDyPRr4cQ83wy_nw2y-T_2eD
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VFAkuvB-BAoMEvRCrjnf92ANCoVC1ahtFNKByMut9tJbSuMRJUPhR3Pl3zK6dROHRWw_cLHu9Go_nuTv7DSEvFBNxnNnjZ9JIj4Um9BKulReKQCRCCSal75pNxN1ucnzMe2vkx_wsjC2rnNtEZ6hVIe0a-VYQYSaTBDwM3px_9WzXKLu7Om-hUYnFvp59w5StfL33Dv_vyyDYed_f3vXqrgKexOhk7CkhmZ_ENDaYulDDMQCiMQ-NpMzwkEWBxCzJUJ5khvtaaqpCQUMjMoz1BVOG4rxXyDqzwt4g6729w97n5aqOw3fz69M5Pk22SvSQDDN2zPksMmPboyse0DUK-Ft0-2eR5m87tc4B7tz831h3i9yoQ23oVLpxm6zp4R2y2auwumct6C-PnpUt2ITeEsV7dpf87IBdRhloyC1nhqLEuVRRaigMuM6GYGHT86rJy3cB03w0KcEuaQP1pm4zRCuYCmlLF3AShUpUQlU_gy4GUKTzrFAzvFBwZgueZ9AHu5ECo6pw2b4FGKDDAC1y6cbVsBolnIozC3GBd0-QhnIMR50PR9528ckL7pGPl8LW-6QxLIb6IYF2FAphmKKZjduiiGN8rk3sm0zHOmCmSdpz2UtlDQJve5EMUleMQJO0ktcU5TV18prSJnm1eOe8gkC5cPRbK9KLkRa-3N0oRidpbQ1TE5uER5oJYzjLdCJiibFURFXbFyLJVJNszCU5rW1qmS7FuEmeLx6jNbR_Rgx1MXFjLOIdOpUmeVDpz4ISiqxMeIwUxiuatULq6pNhfuoQ17mFofTDJmnNdXBJ1r9Z8ejir3hGru32Dw_Sg73u_mNyPXAmgnlBuEEa49FEPyFX5XScl6OntZUB8uWytfMXwa68pg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+single+intranasal+dose+of+human+parainfluenza+virus+type+3-vectored+vaccine+induces+effective+antibody+and+memory+T+cell+response+in+the+lungs+and+protects+hamsters+against+SARS-CoV-2&rft.jtitle=npj+vaccines&rft.au=Ilinykh%2C+Philipp+A.&rft.au=Periasamy%2C+Sivakumar&rft.au=Huang%2C+Kai&rft.au=Kuzmina%2C+Natalia+A.&rft.date=2022-04-25&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2059-0105&rft.volume=7&rft.issue=1&rft_id=info:doi/10.1038%2Fs41541-022-00471-3&rft.externalDocID=10_1038_s41541_022_00471_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-0105&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-0105&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-0105&client=summon